Generation Bio Co. Sustainability Profile
Generation Bio Co., headquartered in the United States, is a pioneering biotechnology company focused on developing transformative gene therapies. Founded in 2016, the company has rapidly advanced its proprietary gene delivery platform, which aims to provide durable and potentially curative treatments for genetic diseases. With a strong emphasis on innovation, Generation Bio's core offerings include its unique non-viral gene therapy solutions, designed to overcome the limitations of traditional viral vectors. This approach positions the company at the forefront of the gene therapy industry, enabling it to address a wide range of genetic disorders. Notable achievements include significant funding rounds and strategic partnerships that have bolstered its market presence. As a leader in the biotechnology sector, Generation Bio is committed to advancing the future of medicine through its cutting-edge research and development initiatives.
DitchCarbon Score
How does Generation Bio Co.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Generation Bio Co.'s score of 29 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Generation Bio Co.'s reported carbon emissions
Generation Bio Co., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year. However, the company is actively engaged in climate commitments aimed at achieving significant reductions in its carbon footprint. Generation Bio has set ambitious targets for carbon neutrality across its operations. The company aims to achieve carbon neutrality in Scope 1 and Scope 2 emissions by 2030. This near-term goal reflects a commitment to reducing direct and indirect emissions associated with its operations and energy use. In addition to its near-term targets, Generation Bio is also focused on long-term sustainability. The company is working towards net zero emissions from its operations by 2050, with interim targets to reduce emissions to 2020 levels by 2030. These initiatives align with industry standards and demonstrate a proactive approach to addressing climate change. While specific emissions data is not available, Generation Bio's commitments indicate a strong dedication to environmental stewardship and a strategic plan for reducing its carbon emissions in the coming years.
How Carbon Intensive is Generation Bio Co.'s Industry?
How Carbon Intensive is Generation Bio Co.'s Location?
Generation Bio Co.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Generation Bio Co. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
